OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polo-like kinase 1 (PLK1) signaling in cancer and beyond
Styliani Iliaki, Rudi Beyaert, Inna S. Afonina
Biochemical Pharmacology (2021) Vol. 193, pp. 114747-114747
Closed Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Present and Future Perspective on PLK1 Inhibition in Cancer Treatment
Michela Chiappa, Serena Petrella, Giovanna Damia, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 83

Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling
Kinjal Shah, Julhash U. Kazi
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 55

DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target
Maojian Chen, Shaoping Zhang, Fan Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12

Targeting Focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders
Xiao Wang, Na Li, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116678-116678
Closed Access | Times Cited: 12

Ubiquitin-specific proteases: From biological functions to potential therapeutic applications in gastric cancer
Kaiqiang Li, Xiao Bai, Angting Ke, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116323-116323
Open Access | Times Cited: 9

From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9

Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions
Nuno Jorge Lamas, Arnaud Martel, Sacha Nahon‐Estève, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 96-96
Open Access | Times Cited: 43

The Promise of Combination Therapies with FOXM1 Inhibitors for Cancer Treatment
Nawal Merjaneh, Mona Hajjar, Ying‐Wei Lan, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 756-756
Open Access | Times Cited: 8

Coregulation of NDC80 Complex Subunits Determines the Fidelity of the Spindle-Assembly Checkpoint and Mitosis
Sehong Kim, Thomas T.Y. Lau, Man Kit Liao, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 5, pp. 423-439
Open Access | Times Cited: 6

Hydrophobic tagging of small molecules: an overview of the literature and future outlook
Yang Zhou, Fan Zhou, Shujing Xu, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 7, pp. 799-813
Closed Access | Times Cited: 6

Cyclers’ kinases in cell division: from molecules to cancer therapy
Giacomo Milletti, Valeria Colicchia, Francesco Cecconi
Cell Death and Differentiation (2023) Vol. 30, Iss. 9, pp. 2035-2052
Open Access | Times Cited: 15

Engineered mesoporous silica nanoparticles, new insight nanoplatforms into effective cancer gene therapy
Razieh Heidari, Vahideh Assadollahi, Pegah Khosravian, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127060-127060
Closed Access | Times Cited: 14

Using Chitosan-Stabilized, Hyaluronic Acid-Modified Selenium Nanoparticles to Deliver CD44-Targeted PLK1 siRNAs for Treating Bladder Cancer
Maryamsadat Shahidi, Omid Abazari, Parisa Dayati, et al.
Nanomedicine (2023) Vol. 18, Iss. 3, pp. 259-277
Closed Access | Times Cited: 11

The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors
Xavier T.R. Moore, Lilia Gheghiani, Zheng Fu
Cells (2023) Vol. 12, Iss. 9, pp. 1344-1344
Open Access | Times Cited: 11

Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas
Michela Chiappa, Alessandra Decio, Luca Guarrera, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 4

Decoding oral cancer: insights from miRNA expression profiles and their regulatory targets
Xin Wang, Shuang Zhang, Shuyi Wang, et al.
Frontiers in Molecular Biosciences (2025) Vol. 11
Open Access

Temporal Myc dynamics permit mitotic bypass, promoting polyploid phenotypes
Michael A. Loycano, Kenneth J. Pienta, Sarah R. Amend
Cancer Letters (2025) Vol. 613, pp. 217526-217526
Closed Access

Spatio-temporal control of mitosis using light via a Plk1 inhibitor caged for activity and cellular permeability
Victoria von Glasenapp, Ana C. Almeida, Dalu Chang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Crosstalk Between Plk1 and PTEN in Mitosis Affects Chromosomal Stability
Wei Li, Xianning Wang, Jiannan Liu, et al.
DNA and Cell Biology (2025)
Closed Access

Casticin and chrysosplenol D from Artemisia annua L. induce apoptosis by inhibiting topoisomerase IIα in human non-small-cell lung cancer cells
Chunqing Fu, Keyu Zhang, Manyuan Wang, et al.
Phytomedicine (2022) Vol. 100, pp. 154095-154095
Closed Access | Times Cited: 17

E2F2 promotes lung adenocarcinoma progression through B-Myb- and FOXM1-facilitated core transcription regulatory circuitry
Kailong Du, Shijie Sun, Tinghui Jiang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 10, pp. 4151-4170
Open Access | Times Cited: 17

Page 1 - Next Page

Scroll to top